A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood

Ulrich Thalheimer, Christos K. Triantos, Dimitrios N. Samonakis, Andrea Zambruni, Marco Senzolo, Gioacchino Leandro, David Patch, Andrew K. Burroughs

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Thromboelastography can be performed with native or citrated blood (a surrogate to native blood in healthy controls, surgical and cirrhotic patients). Activators such as kaolin are increasingly used to reduce the time to trace generation. To compare kaolin-activated thromboelastography with nonkaolin-activated thromboelastography of native and citrated blood in patients with liver disease, patients undergoing treatment with warfarin or low-molecular weight heparin and healthy volunteers. We studied thromboelastography parameters in 21 healthy volunteers (group 1) and 50 patients, including 20 patients with liver cirrhosis with a nonbiliary aetiology (group 2), 10 patients with primary biliary cirrhosis or primary sclerosing cholangitis (group 3), 10 patients on warfarin treatment (group 4) and 10 patients with enoxaparin prophylaxis (group 5). Thromboelastography was performed using four methods: native blood (kaolin-activated and nonkaolin-activated) and citrated blood (kaolin-activated and nonkaolin-activated). For all thromboelastography parameters, correlation was poor (Spearman correlation coefficient <0.70) between nonkaolin-activated and kaolin-activated thromboelastography, for both citrated and native blood. In healthy volunteers, in patients with liver disease and in those receiving anticoagulant treatment, there was a poor correlation between nonkaolin-activated and kaolin-activated thromboelastography. Kaolin-activated thromboelastography needs further validation before routine clinical use in these settings, and the specific methodology must be considered in comparing published studies.

Original languageEnglish
Pages (from-to)495-501
Number of pages7
JournalBlood Coagulation and Fibrinolysis
Volume19
Issue number6
DOIs
Publication statusPublished - Sep 2008

Fingerprint

Thrombelastography
Kaolin
Healthy Volunteers
Warfarin
Liver Diseases
Enoxaparin
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Low Molecular Weight Heparin
Liver Cirrhosis
Anticoagulants
Therapeutics

Keywords

  • Anticoagulants
  • Liver disease
  • Thromboelastography

ASJC Scopus subject areas

  • Hematology

Cite this

A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood. / Thalheimer, Ulrich; Triantos, Christos K.; Samonakis, Dimitrios N.; Zambruni, Andrea; Senzolo, Marco; Leandro, Gioacchino; Patch, David; Burroughs, Andrew K.

In: Blood Coagulation and Fibrinolysis, Vol. 19, No. 6, 09.2008, p. 495-501.

Research output: Contribution to journalArticle

Thalheimer, U, Triantos, CK, Samonakis, DN, Zambruni, A, Senzolo, M, Leandro, G, Patch, D & Burroughs, AK 2008, 'A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood', Blood Coagulation and Fibrinolysis, vol. 19, no. 6, pp. 495-501. https://doi.org/10.1097/MBC.0b013e3282f9adf9
Thalheimer, Ulrich ; Triantos, Christos K. ; Samonakis, Dimitrios N. ; Zambruni, Andrea ; Senzolo, Marco ; Leandro, Gioacchino ; Patch, David ; Burroughs, Andrew K. / A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood. In: Blood Coagulation and Fibrinolysis. 2008 ; Vol. 19, No. 6. pp. 495-501.
@article{339ac9bff30541f0a1cbf3a6ab3f6389,
title = "A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood",
abstract = "Thromboelastography can be performed with native or citrated blood (a surrogate to native blood in healthy controls, surgical and cirrhotic patients). Activators such as kaolin are increasingly used to reduce the time to trace generation. To compare kaolin-activated thromboelastography with nonkaolin-activated thromboelastography of native and citrated blood in patients with liver disease, patients undergoing treatment with warfarin or low-molecular weight heparin and healthy volunteers. We studied thromboelastography parameters in 21 healthy volunteers (group 1) and 50 patients, including 20 patients with liver cirrhosis with a nonbiliary aetiology (group 2), 10 patients with primary biliary cirrhosis or primary sclerosing cholangitis (group 3), 10 patients on warfarin treatment (group 4) and 10 patients with enoxaparin prophylaxis (group 5). Thromboelastography was performed using four methods: native blood (kaolin-activated and nonkaolin-activated) and citrated blood (kaolin-activated and nonkaolin-activated). For all thromboelastography parameters, correlation was poor (Spearman correlation coefficient <0.70) between nonkaolin-activated and kaolin-activated thromboelastography, for both citrated and native blood. In healthy volunteers, in patients with liver disease and in those receiving anticoagulant treatment, there was a poor correlation between nonkaolin-activated and kaolin-activated thromboelastography. Kaolin-activated thromboelastography needs further validation before routine clinical use in these settings, and the specific methodology must be considered in comparing published studies.",
keywords = "Anticoagulants, Liver disease, Thromboelastography",
author = "Ulrich Thalheimer and Triantos, {Christos K.} and Samonakis, {Dimitrios N.} and Andrea Zambruni and Marco Senzolo and Gioacchino Leandro and David Patch and Burroughs, {Andrew K.}",
year = "2008",
month = "9",
doi = "10.1097/MBC.0b013e3282f9adf9",
language = "English",
volume = "19",
pages = "495--501",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood

AU - Thalheimer, Ulrich

AU - Triantos, Christos K.

AU - Samonakis, Dimitrios N.

AU - Zambruni, Andrea

AU - Senzolo, Marco

AU - Leandro, Gioacchino

AU - Patch, David

AU - Burroughs, Andrew K.

PY - 2008/9

Y1 - 2008/9

N2 - Thromboelastography can be performed with native or citrated blood (a surrogate to native blood in healthy controls, surgical and cirrhotic patients). Activators such as kaolin are increasingly used to reduce the time to trace generation. To compare kaolin-activated thromboelastography with nonkaolin-activated thromboelastography of native and citrated blood in patients with liver disease, patients undergoing treatment with warfarin or low-molecular weight heparin and healthy volunteers. We studied thromboelastography parameters in 21 healthy volunteers (group 1) and 50 patients, including 20 patients with liver cirrhosis with a nonbiliary aetiology (group 2), 10 patients with primary biliary cirrhosis or primary sclerosing cholangitis (group 3), 10 patients on warfarin treatment (group 4) and 10 patients with enoxaparin prophylaxis (group 5). Thromboelastography was performed using four methods: native blood (kaolin-activated and nonkaolin-activated) and citrated blood (kaolin-activated and nonkaolin-activated). For all thromboelastography parameters, correlation was poor (Spearman correlation coefficient <0.70) between nonkaolin-activated and kaolin-activated thromboelastography, for both citrated and native blood. In healthy volunteers, in patients with liver disease and in those receiving anticoagulant treatment, there was a poor correlation between nonkaolin-activated and kaolin-activated thromboelastography. Kaolin-activated thromboelastography needs further validation before routine clinical use in these settings, and the specific methodology must be considered in comparing published studies.

AB - Thromboelastography can be performed with native or citrated blood (a surrogate to native blood in healthy controls, surgical and cirrhotic patients). Activators such as kaolin are increasingly used to reduce the time to trace generation. To compare kaolin-activated thromboelastography with nonkaolin-activated thromboelastography of native and citrated blood in patients with liver disease, patients undergoing treatment with warfarin or low-molecular weight heparin and healthy volunteers. We studied thromboelastography parameters in 21 healthy volunteers (group 1) and 50 patients, including 20 patients with liver cirrhosis with a nonbiliary aetiology (group 2), 10 patients with primary biliary cirrhosis or primary sclerosing cholangitis (group 3), 10 patients on warfarin treatment (group 4) and 10 patients with enoxaparin prophylaxis (group 5). Thromboelastography was performed using four methods: native blood (kaolin-activated and nonkaolin-activated) and citrated blood (kaolin-activated and nonkaolin-activated). For all thromboelastography parameters, correlation was poor (Spearman correlation coefficient <0.70) between nonkaolin-activated and kaolin-activated thromboelastography, for both citrated and native blood. In healthy volunteers, in patients with liver disease and in those receiving anticoagulant treatment, there was a poor correlation between nonkaolin-activated and kaolin-activated thromboelastography. Kaolin-activated thromboelastography needs further validation before routine clinical use in these settings, and the specific methodology must be considered in comparing published studies.

KW - Anticoagulants

KW - Liver disease

KW - Thromboelastography

UR - http://www.scopus.com/inward/record.url?scp=58149107965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149107965&partnerID=8YFLogxK

U2 - 10.1097/MBC.0b013e3282f9adf9

DO - 10.1097/MBC.0b013e3282f9adf9

M3 - Article

VL - 19

SP - 495

EP - 501

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 6

ER -